Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07452016 · ClinicalTrials.gov registry record · NA
AI-guided Prediction and Treatment of Cardiac Arrest
A NA study, sponsored by MetroHealth Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT07452016 is a NA study that has not yet begun recruiting, run by MetroHealth Medical Center. The registered enrollment target is 68 participants.
The verdict
NCT07452016, a NA study, has not yet begun recruiting, sponsored by MetroHealth Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
Sudden cardiac arrest is a major health problem, and most people don't survive. One big reason is that even if resuscitation is successful, people commonly have recurrent cardiac arrests (rearrest). Right now, it is not possible to accurately predict a rearrest or prevent it. The investigators have developed a machine learning device that uses the heart tracing (ECG) to predict when and why a rearrest occurs. The investigators plan to test if it will accurately and effectively help EMS providers predict rearrest and provide timely treatment to increase survival after cardiac arrest. To determine if this machine learning device will work in the real world, the investigators need to find out if there are barriers to using it, and whether EMS providers will think it is useful and will help them improve the care of patients who have a cardiac arrest. The investigators will first test the device in live simulated cardiac arrest scenarios to see if the providers can use it and if they find the device potentially valuable in taking care of patients. In a second study, the investigators will test how accurate the device is in predicting if a cardiac arrest will happen again in patients who have just been brought back to life after a cardiac arrest. EMS providers will attach the device, but it will only work in the background. EMS will take care of patients as they normally would, without using or knowing what the device says. To see if the device is accurate at predicting another cardiac arrest, the investigators will analyze the results offline, and compare what the device says to what actually happens to the patient. By comparing what the device predicts to what actually happens, the investigators can see how well it predicts another cardiac arrest and estimate how it might improve treatment of patients.
Interventions
- DEVICE Machine learning-guided cardiac arrest prediction device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2026-08 |
| Est. Completion | 2029-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07452016
The ClinicalTrials.gov registry entry for NCT07452016 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Machine learning-guided cardiac arrest prediction device is the first listed.
NCT07452016 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07452016 about?
NCT07452016 is a clinical study titled "AI-guided Prediction and Treatment of Cardiac Arrest". Sudden cardiac arrest is a major health problem, and most people don't survive. One big reason is that even if resuscitation is successful, people commonly have recurrent cardiac arrests (rearrest). Right now, it is not possible to accurately predict a rearrest or prevent it. The investigators have ...
What is the current status of trial NCT07452016?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2026-08. Estimated completion is 2029-06.
What interventions are being tested in trial NCT07452016?
The interventions under investigation include: Machine learning-guided cardiac arrest prediction device (DEVICE).
Who is sponsoring clinical trial NCT07452016?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.